Bachem Holding AG
SIX:BANB

Watchlist Manager
Bachem Holding AG Logo
Bachem Holding AG
SIX:BANB
Watchlist
Price: 67.5 CHF -3.3% Market Closed
Market Cap: 5.1B CHF
Have any thoughts about
Bachem Holding AG?
Write Note

Bachem Holding AG
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bachem Holding AG
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Bachem Holding AG
SIX:BANB
Accounts Receivables
CHf136m
CAGR 3-Years
22%
CAGR 5-Years
17%
CAGR 10-Years
15%
Siegfried Holding AG
SIX:SFZN
Accounts Receivables
CHf355.2m
CAGR 3-Years
17%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Lonza Group AG
SIX:LONN
Accounts Receivables
CHf1.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Tecan Group AG
SIX:TECN
Accounts Receivables
CHf183m
CAGR 3-Years
18%
CAGR 5-Years
12%
CAGR 10-Years
N/A
PolyPeptide Group AG
SIX:PPGN
Accounts Receivables
€78.8m
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
N/A
SKAN Group AG
SIX:SKAN
Accounts Receivables
CHf26.5m
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Bachem Holding AG
Glance View

Market Cap
5.1B CHF
Industry
Life Sciences Tools & Services

Bachem Holding AG engages in the provision of peptides and oligonucleotides. The company is headquartered in Bubendorf, Basel-Landschaft and currently employs 1,639 full-time employees. The company went IPO on 2001-06-29. The firm focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the fluorescence energy transfer (FRET) analysis of receptor-ligand interactions, protein-protein interactions and the cleavage of substrate molecules, as well as glycosylated peptides for the manipulation of drug properties. The firm markets products under the Bachem and Clinalfa brands and operates production facilities in Switzerland and in the United States.

BANB Intrinsic Value
90.95 CHF
Undervaluation 26%
Intrinsic Value
Price

See Also

What is Bachem Holding AG's Accounts Receivables?
Accounts Receivables
136m CHF

Based on the financial report for Jun 30, 2024, Bachem Holding AG's Accounts Receivables amounts to 136m CHF.

What is Bachem Holding AG's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
15%

Over the last year, the Accounts Receivables growth was 4%. The average annual Accounts Receivables growth rates for Bachem Holding AG have been 22% over the past three years , 17% over the past five years , and 15% over the past ten years .

Back to Top